To stop or not to stop: what should we be doing with biologic DMARDs when patients undergo orthopaedic surgery?

Detalles Bibliográficos
Autores principales: van Duren, Bernard H, Wignall, Alice, Rangan, Amar, Coates, Laura, Pandit, Hemant, Mankia, Kulveer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Letter to the Editor (Other)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493102/
https://www.ncbi.nlm.nih.gov/pubmed/34622125
http://dx.doi.org/10.1093/rap/rkab057
_version_ 1784579061264154624
author van Duren, Bernard H
Wignall, Alice
Rangan, Amar
Coates, Laura
Pandit, Hemant
Mankia, Kulveer
author_facet van Duren, Bernard H
Wignall, Alice
Rangan, Amar
Coates, Laura
Pandit, Hemant
Mankia, Kulveer
author_sort van Duren, Bernard H
collection PubMed
description
format Online
Article
Text
id pubmed-8493102
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-84931022021-10-06 To stop or not to stop: what should we be doing with biologic DMARDs when patients undergo orthopaedic surgery? van Duren, Bernard H Wignall, Alice Rangan, Amar Coates, Laura Pandit, Hemant Mankia, Kulveer Rheumatol Adv Pract Letter to the Editor (Other) Oxford University Press 2021-09-27 /pmc/articles/PMC8493102/ /pubmed/34622125 http://dx.doi.org/10.1093/rap/rkab057 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Letter to the Editor (Other)
van Duren, Bernard H
Wignall, Alice
Rangan, Amar
Coates, Laura
Pandit, Hemant
Mankia, Kulveer
To stop or not to stop: what should we be doing with biologic DMARDs when patients undergo orthopaedic surgery?
title To stop or not to stop: what should we be doing with biologic DMARDs when patients undergo orthopaedic surgery?
title_full To stop or not to stop: what should we be doing with biologic DMARDs when patients undergo orthopaedic surgery?
title_fullStr To stop or not to stop: what should we be doing with biologic DMARDs when patients undergo orthopaedic surgery?
title_full_unstemmed To stop or not to stop: what should we be doing with biologic DMARDs when patients undergo orthopaedic surgery?
title_short To stop or not to stop: what should we be doing with biologic DMARDs when patients undergo orthopaedic surgery?
title_sort to stop or not to stop: what should we be doing with biologic dmards when patients undergo orthopaedic surgery?
topic Letter to the Editor (Other)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493102/
https://www.ncbi.nlm.nih.gov/pubmed/34622125
http://dx.doi.org/10.1093/rap/rkab057
work_keys_str_mv AT vandurenbernardh tostopornottostopwhatshouldwebedoingwithbiologicdmardswhenpatientsundergoorthopaedicsurgery
AT wignallalice tostopornottostopwhatshouldwebedoingwithbiologicdmardswhenpatientsundergoorthopaedicsurgery
AT ranganamar tostopornottostopwhatshouldwebedoingwithbiologicdmardswhenpatientsundergoorthopaedicsurgery
AT coateslaura tostopornottostopwhatshouldwebedoingwithbiologicdmardswhenpatientsundergoorthopaedicsurgery
AT pandithemant tostopornottostopwhatshouldwebedoingwithbiologicdmardswhenpatientsundergoorthopaedicsurgery
AT mankiakulveer tostopornottostopwhatshouldwebedoingwithbiologicdmardswhenpatientsundergoorthopaedicsurgery

Ejemplares similares